rx 821002 has been researched along with ketamine in 2 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
---|---|---|---|---|---|
317 | 0 | 45 | 15,029 | 2,321 | 6,678 |
Protein | Taxonomy | rx 821002 (IC50) | ketamine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delima, EC; Rietkerk, FE | 1 |
García-Fuster, MJ; García-Sevilla, JA | 1 |
2 other study(ies) available for rx 821002 and ketamine
Article | Year |
---|---|
Clinical and haematological changes in gazelles during xylazine/ketamine anaesthesia and following reversal with RX-821002A.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antelopes; Blood Cell Count; Dioxanes; Hemodynamics; Idazoxan; Injections, Intravenous; Ketamine; Male; Xylazine | 1994 |
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |